AMENDMENT NO. 5 TO LICENSE AGREEMENTLicense Agreement • August 14th, 2009 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 5 to License Agreement (the “Amendment”) is made and entered into as of the 23rd day of June, 2009 (“Effective Date”), by and between SOLVAY PHARMACEUTICALS, INC., a Georgia corporation having its principal office at 901 Sawyer Road, Marietta, Georgia 30062 (“Solvay”) and JPI COMMERCIAL, LLC, a Delaware limited liability corporation and wholly-owned subsidiary of Jazz Pharmaceuticals, Inc., a Delaware corporation (“Jazz Pharmaceuticals”), having its principal offices at 3180 Porter Drive, Palo Alto, California 94304 (“JPI”). Solvay and JPI are referred to herein on occasion separately as a “Party” or together as the “Parties”. Capitalized terms used herein shall have their respective meanings set forth in the License Agreement, unless otherwise defined herein.
JAZZ PHARMACEUTICALS, INC. WAIVER AND AMENDMENT AGREEMENTInvestor Rights Agreement • August 14th, 2009 • Jazz Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS WAIVER AND AMENDMENT AGREEMENT (the “Agreement”) is made effective as of July 6, 2009 (the “Effective Date”), by and among JAZZ PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and the undersigned Holders (the “Consenting Holders”).
